Inhibition of sodium- and potassium-dependent adenosine triphosphatase by N-ethylmaleimide. II. Effects of sodium-activated transphosphorylation.
D000227:Adenine Nucleotides; D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D002247:Carbon Isotopes; D005033:Ethylmaleimide / Q000494:pharmacology*; D006168:Guinea Pigs; D007668:Kidney / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D008274:Magnesium / Q000494:pharmacology; D008861:Microsomes / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D010042:Ouabain / Q000378:metabolism / Q000494:pharmacology; D010085:Oxidative Phosphorylation / Q000187:drug effects; D010750:Phosphoproteins / Q000096:biosynthesis; D010759:Phosphorus Isotopes; D010770:Phosphotransferases; D011188:Potassium / Q000494:pharmacology; D011487:Protein Conformation; D012964:Sodium / Q000494:pharmacology*; D014316:Tritium
D000227:Adenine Nucleotides; D002247:Carbon Isotopes; D010750:Phosphoproteins; D010759:Phosphorus Isotopes; D014316:Tritium; D010042:Ouabain; D000255:Adenosine Triphosphate; D012964:Sodium; D010770:Phosphotransferases; D000251:Adenosine Triphosphatases; D008274:Magnesium; D005033:Ethylmaleimide; D011188:Potassium